Moleculin Biotech Inc (MBRX)
2.90
+0.07
(+2.47%)
USD |
NASDAQ |
Nov 22, 16:00
2.90
0.00 (0.00%)
After-Hours: 19:16
Moleculin Biotech Total Assets (Quarterly): 23.39M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 23.39M |
| June 30, 2024 | 25.58M |
| March 31, 2024 | 30.84M |
| December 31, 2023 | 38.22M |
| September 30, 2023 | 39.52M |
| June 30, 2023 | 47.12M |
| March 31, 2023 | 51.06M |
| December 31, 2022 | 57.42M |
| September 30, 2022 | 65.37M |
| June 30, 2022 | 73.26M |
| March 31, 2022 | 78.80M |
| December 31, 2021 | 84.09M |
| September 30, 2021 | 88.70M |
| June 30, 2021 | 93.53M |
| March 31, 2021 | 99.78M |
| December 31, 2020 | 29.03M |
| September 30, 2020 | 27.14M |
| June 30, 2020 | 31.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.47M |
| December 31, 2019 | 25.24M |
| September 30, 2019 | 30.40M |
| June 30, 2019 | 31.85M |
| March 31, 2019 | 21.30M |
| December 31, 2018 | 19.58M |
| September 30, 2018 | 20.90M |
| June 30, 2018 | 24.07M |
| March 31, 2018 | 24.93M |
| December 31, 2017 | 19.48M |
| September 30, 2017 | 20.63M |
| June 30, 2017 | 21.25M |
| March 31, 2017 | 20.32M |
| December 31, 2016 | 16.39M |
| September 30, 2016 | 17.57M |
| June 30, 2016 | 19.23M |
| March 31, 2016 | 0.2897M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.39M
Minimum
Sep 2024
99.78M
Maximum
Mar 2021
51.75M
Average
43.32M
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies Inc | 11.00B |
| Seelos Therapeutics Inc | 2.381M |
| Cara Therapeutics Inc | 51.33M |
| Citius Pharmaceuticals Inc | 97.09M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.92M |
| Shareholders Equity (Quarterly) | 7.479M |